Home > > > > Report Detail

Global Biosimilar Monoclonal Antibodies Market Growth 2020-2025

Publisher Name :
Date: 31-Aug-2020
No. of pages: 139

According to this study, over the next five years the Biosimilar Monoclonal Antibodies market will register a 28.7%% CAGR in terms of revenue, the global market size will reach $ 12290 million by 2025, from $ 4474.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Monoclonal Antibodies business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Biosimilar Monoclonal Antibodies, covering the supply chain analysis, impact assessment to the Biosimilar Monoclonal Antibodies market size growth rate in several scenarios, and the measures to be undertaken by Biosimilar Monoclonal Antibodies companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Infliximab

- Rituximab

- Trastuzumab

- Adalimumab

- Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Oncology

- Autoimmune Disease

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Celltrion

- Pfizer (Hospira)

- Novartis (Sandoz)

- Dr Reddy's

- 3SBIO

- Hisun Pharma

- Celgen Biopharma

- Torrent Pharmaceuticals

- Cadila Healthcare

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Biosimilar Monoclonal Antibodies consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.

- Focuses on the key global Biosimilar Monoclonal Antibodies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Biosimilar Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Biosimilar Monoclonal Antibodies Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Monoclonal Antibodies Consumption 2015-2025
2.1.2 Biosimilar Monoclonal Antibodies Consumption CAGR by Region
2.2 Biosimilar Monoclonal Antibodies Segment by Type
2.2.1 Infliximab
2.2.2 Rituximab
2.2.3 Trastuzumab
2.2.4 Adalimumab
2.2.5 Other
2.3 Biosimilar Monoclonal Antibodies Consumption by Type
2.3.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2015-2020)
2.4 Biosimilar Monoclonal Antibodies Segment by Application
2.4.1 Oncology
2.4.2 Autoimmune Disease
2.4.3 Other
2.5 Biosimilar Monoclonal Antibodies Consumption by Application
2.5.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
2.5.2 Global Biosimilar Monoclonal Antibodies Value and Market Share by Type (2015-2020)
2.5.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2015-2020)

3 Global Biosimilar Monoclonal Antibodies by Company
3.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Company
3.1.1 Global Biosimilar Monoclonal Antibodies Sales by Company (2018-2020)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Company (2018-2020)
3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Company (2018-2020)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2018-2020)
3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Company
3.4 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biosimilar Monoclonal Antibodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Monoclonal Antibodies by Regions
4.1 Biosimilar Monoclonal Antibodies by Regions
4.2 Americas Biosimilar Monoclonal Antibodies Consumption Growth
4.3 APAC Biosimilar Monoclonal Antibodies Consumption Growth
4.4 Europe Biosimilar Monoclonal Antibodies Consumption Growth
4.5 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Growth

5 Americas
5.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries
5.1.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020)
5.1.2 Americas Biosimilar Monoclonal Antibodies Value by Countries (2015-2020)
5.2 Americas Biosimilar Monoclonal Antibodies Consumption by Type
5.3 Americas Biosimilar Monoclonal Antibodies Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biosimilar Monoclonal Antibodies Consumption by Regions
6.1.1 APAC Biosimilar Monoclonal Antibodies Consumption by Regions (2015-2020)
6.1.2 APAC Biosimilar Monoclonal Antibodies Value by Regions (2015-2020)
6.2 APAC Biosimilar Monoclonal Antibodies Consumption by Type
6.3 APAC Biosimilar Monoclonal Antibodies Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies by Countries
7.1.1 Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020)
7.1.2 Europe Biosimilar Monoclonal Antibodies Value by Countries (2015-2020)
7.2 Europe Biosimilar Monoclonal Antibodies Consumption by Type
7.3 Europe Biosimilar Monoclonal Antibodies Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Monoclonal Antibodies by Countries
8.1.1 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2015-2020)
8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type
8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Monoclonal Antibodies Distributors
10.3 Biosimilar Monoclonal Antibodies Customer

11 Global Biosimilar Monoclonal Antibodies Market Forecast
11.1 Global Biosimilar Monoclonal Antibodies Consumption Forecast (2021-2025)
11.2 Global Biosimilar Monoclonal Antibodies Forecast by Regions
11.2.1 Global Biosimilar Monoclonal Antibodies Forecast by Regions (2021-2025)
11.2.2 Global Biosimilar Monoclonal Antibodies Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Monoclonal Antibodies Forecast by Type
11.8 Global Biosimilar Monoclonal Antibodies Forecast by Application

12 Key Players Analysis
12.1 Celltrion
12.1.1 Company Information
12.1.2 Biosimilar Monoclonal Antibodies Product Offered
12.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Celltrion Latest Developments
12.2 Pfizer (Hospira)
12.2.1 Company Information
12.2.2 Biosimilar Monoclonal Antibodies Product Offered
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer (Hospira) Latest Developments
12.3 Novartis (Sandoz)
12.3.1 Company Information
12.3.2 Biosimilar Monoclonal Antibodies Product Offered
12.3.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis (Sandoz) Latest Developments
12.4 Dr Reddy's
12.4.1 Company Information
12.4.2 Biosimilar Monoclonal Antibodies Product Offered
12.4.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Dr Reddy's Latest Developments
12.5 3SBIO
12.5.1 Company Information
12.5.2 Biosimilar Monoclonal Antibodies Product Offered
12.5.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 3SBIO Latest Developments
12.6 Hisun Pharma
12.6.1 Company Information
12.6.2 Biosimilar Monoclonal Antibodies Product Offered
12.6.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Hisun Pharma Latest Developments
12.7 Celgen Biopharma
12.7.1 Company Information
12.7.2 Biosimilar Monoclonal Antibodies Product Offered
12.7.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Celgen Biopharma Latest Developments
12.8 Torrent Pharmaceuticals
12.8.1 Company Information
12.8.2 Biosimilar Monoclonal Antibodies Product Offered
12.8.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Torrent Pharmaceuticals Latest Developments
12.9 Cadila Healthcare
12.9.1 Company Information
12.9.2 Biosimilar Monoclonal Antibodies Product Offered
12.9.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Cadila Healthcare Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Biosimilar Monoclonal Antibodies Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Infliximab
Table 5. Major Players of Rituximab
Table 6. Major Players of Trastuzumab
Table 7. Major Players of Adalimumab
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 11. Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020) ($ million)
Table 12. Global Biosimilar Monoclonal Antibodies Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Biosimilar Monoclonal Antibodies Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 16. Global Biosimilar Monoclonal Antibodies Value by Application (2015-2020)
Table 17. Global Biosimilar Monoclonal Antibodies Value Market Share by Application (2015-2020)
Table 18. Global Biosimilar Monoclonal Antibodies Sale Price by Application (2015-2020)
Table 19. Global Biosimilar Monoclonal Antibodies Sales by Company (2017-2019) (K Units)
Table 20. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company (2017-2019)
Table 21. Global Biosimilar Monoclonal Antibodies Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2017-2019)
Table 23. Global Biosimilar Monoclonal Antibodies Sale Price by Company (2017-2019)
Table 24. Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Biosimilar Monoclonal Antibodies Products Offered
Table 26. Biosimilar Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Biosimilar Monoclonal Antibodies Consumption by Regions 2015-2020 (K Units)
Table 28. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2015-2020
Table 29. Global Biosimilar Monoclonal Antibodies Value by Regions 2015-2020 ($ Millions)
Table 30. Global Biosimilar Monoclonal Antibodies Value Market Share by Regions 2015-2020
Table 31. Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 33. Americas Biosimilar Monoclonal Antibodies Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Biosimilar Monoclonal Antibodies Value Market Share by Countries (2015-2020)
Table 35. Americas Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 36. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 37. Americas Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 38. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 39. APAC Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 41. APAC Biosimilar Monoclonal Antibodies Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Biosimilar Monoclonal Antibodies Value Market Share by Regions (2015-2020)
Table 43. APAC Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 44. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 45. APAC Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 46. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 47. Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 49. Europe Biosimilar Monoclonal Antibodies Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Biosimilar Monoclonal Antibodies Value Market Share by Countries (2015-2020)
Table 51. Europe Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 52. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 53. Europe Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 54. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Biosimilar Monoclonal Antibodies Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 63. Biosimilar Monoclonal Antibodies Distributors List
Table 64. Biosimilar Monoclonal Antibodies Customer List
Table 65. Global Biosimilar Monoclonal Antibodies Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Biosimilar Monoclonal Antibodies Consumption Market Forecast by Regions
Table 67. Global Biosimilar Monoclonal Antibodies Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Regions
Table 69. Global Biosimilar Monoclonal Antibodies Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Biosimilar Monoclonal Antibodies Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Type (2021-2025)
Table 73. Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Biosimilar Monoclonal Antibodies Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Application (2021-2025)
Table 77. Celltrion Product Offered
Table 78. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. Celltrion Main Business
Table 80. Celltrion Latest Developments
Table 81. Celltrion Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer (Hospira) Product Offered
Table 83. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. Pfizer (Hospira) Main Business
Table 85. Pfizer (Hospira) Latest Developments
Table 86. Pfizer (Hospira) Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis (Sandoz) Product Offered
Table 88. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. Novartis (Sandoz) Main Business
Table 90. Novartis (Sandoz) Latest Developments
Table 91. Novartis (Sandoz) Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 92. Dr Reddy's Product Offered
Table 93. Dr Reddy's Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Dr Reddy's Main Business
Table 95. Dr Reddy's Latest Developments
Table 96. Dr Reddy's Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 97. 3SBIO Product Offered
Table 98. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. 3SBIO Main Business
Table 100. 3SBIO Latest Developments
Table 101. 3SBIO Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 102. Hisun Pharma Product Offered
Table 103. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. Hisun Pharma Main Business
Table 105. Hisun Pharma Latest Developments
Table 106. Hisun Pharma Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 107. Celgen Biopharma Product Offered
Table 108. Celgen Biopharma Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 109. Celgen Biopharma Main Business
Table 110. Celgen Biopharma Latest Developments
Table 111. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Torrent Pharmaceuticals Product Offered
Table 113. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. Torrent Pharmaceuticals Main Business
Table 115. Torrent Pharmaceuticals Latest Developments
Table 116. Torrent Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 117. Cadila Healthcare Product Offered
Table 118. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 119. Cadila Healthcare Main Business
Table 120. Cadila Healthcare Latest Developments
Table 121. Cadila Healthcare Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Biosimilar Monoclonal Antibodies
Figure 2. Biosimilar Monoclonal Antibodies Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Biosimilar Monoclonal Antibodies Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Biosimilar Monoclonal Antibodies Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Infliximab
Figure 7. Product Picture of Rituximab
Figure 8. Product Picture of Trastuzumab
Figure 9. Product Picture of Adalimumab
Figure 10. Product Picture of Other
Figure 11. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Figure 12. Global Biosimilar Monoclonal Antibodies Value Market Share by Type (2015-2020)
Figure 13. Biosimilar Monoclonal Antibodies Consumed in Oncology
Figure 14. Global Biosimilar Monoclonal Antibodies Market: Oncology (2015-2020) (K Units)
Figure 15. Global Biosimilar Monoclonal Antibodies Market: Oncology (2015-2020) ($ Millions)
Figure 16. Biosimilar Monoclonal Antibodies Consumed in Autoimmune Disease
Figure 17. Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2015-2020) (K Units)
Figure 18. Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2015-2020) ($ Millions)
Figure 19. Biosimilar Monoclonal Antibodies Consumed in Other
Figure 20. Global Biosimilar Monoclonal Antibodies Market: Other (2015-2020) (K Units)
Figure 21. Global Biosimilar Monoclonal Antibodies Market: Other (2015-2020) ($ Millions)
Figure 22. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Figure 23. Global Biosimilar Monoclonal Antibodies Value Market Share by Application (2015-2020)
Figure 24. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2017
Figure 25. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 26. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company in 2017
Figure 27. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company in 2019
Figure 28. Global Biosimilar Monoclonal Antibodies Sale Price by Company in 2019
Figure 29. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2015-2020
Figure 30. Global Biosimilar Monoclonal Antibodies Value Market Share by Regions 2015-2020
Figure 31. Americas Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 32. Americas Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 33. APAC Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 34. APAC Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 35. Europe Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 36. Europe Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 39. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 40. Americas Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2019
Figure 41. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 42. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 43. United States Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 44. United States Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 50. APAC Biosimilar Monoclonal Antibodies Value Market Share by Regions in 2019
Figure 51. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 52. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 53. China Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 54. China Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 61. India Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 62. India Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 66. Europe Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2019
Figure 67. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 68. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 69. Germany Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 71. France Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 72. France Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 73. UK Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 74. UK Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 83. Egypt Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 93. Global Biosimilar Monoclonal Antibodies Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Biosimilar Monoclonal Antibodies Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 96. Americas Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 97. APAC Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 98. APAC Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 99. Europe Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 100. Europe Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 103. United States Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 104. United States Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 105. Canada Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 106. Canada Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 107. Mexico Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 108. Mexico Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 109. Brazil Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 110. Brazil Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 111. China Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 112. China Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 113. Japan Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 114. Japan Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 115. Korea Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 116. Korea Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 119. India Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 120. India Biosimilar Monoclonal An
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs